Episode Details

Canada just approved its first gene therapy for hemophilia B — a game-changer for patients — but access isn’t equal: Ontario and BC lead the way, while other provinces lag behind. This landmark treatment, given to Canada’s first patient in May, exposes deep disparities in healthcare delivery and sets the stage for how the country balances innovation, affordability, and universal access. How Canada handles this rollout could shape the future of medical breakthroughs nationwide.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/f2296e4c68c387bc